Explore N-Methyllysergamide

ChemSpider 21161369
PubChem 56841679
Wikidata Q83071274

Jacob, P; Shulgin, AT. Structure-activity relationships of the classic hallucinogens and their analogs In Hallucinogens: An update. NIDA Research Monograph 146; Lin, GC; Glennon, RA, Eds., U.S. Department of Health and Human Services, National Institute of Health, U.S. Government Printing Office, Washington, DC, 1 Jan 1994; pp 74–91. 51 kB.

Shulgin, AT. Basic Pharmacology and Effects In Hallucinogens. A Forensic Drug Handbook; Laing, R; Siegel, JA, Eds., Academic Press, London, 24 Apr 2003; pp 67–137. 6.3 MB.

Oberlender, RA. Stereoselective aspects of hallucinogenic drug action and drug discrimination studies of entactogens Ph. D. Thesis, Purdue University, West Lafayette, IN, 1 May 1989. 8.2 MB. MS,NMR,IR,other

Gupta, SP; Singh, P; Bindal, MC. QSAR studies on hallucinogens Chem. Rev., 1 Dec 1983, 83 (6), 633–649. 2.8 MB. https://doi.org/10.1021/cr00058a003 #131

5-(Pyridin-2-ylmethoxy)-AMT · 5-(Pyridin-2-ylmethoxy)-α-methyltryptamine

5-(Pyridin-3-ylmethoxy)-AMT · 5-(Pyridin-3-ylmethoxy)-α-methyltryptamine

5-(Pyridin-4-ylmethoxy)-AMT · 5-(Pyridin-4-ylmethoxy)-α-methyltryptamine